Differential involvement of the Npl4 zinc finger domains of SHARPIN and HOIL-1L in linear ubiquitin chain assembly complex-mediated cell death protection

Molecular and Cellular Biology

Volumn 36, Issue 10, 2016, Pages 1569-1583

  Shimizu, Satoshi ^a,b   Fujita, Hiroaki ^a   Sasaki, Yoshiteru ^a   Tsuruyama, Tatsuaki ^b   Fukuda, Kazuhiko ^b   Iwai, Kazuhiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HOIL 1L PROTEIN; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; NPL4 ZINC FINGER PROTEIN; SHARPIN PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CARRIER PROTEIN; HOIL-1L PROTEIN, MOUSE; LYSINE; SIPL1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CHRONIC PROLIFERATIVE DERMATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DERMATITIS; DISEASE EXACERBATION; EMBRYO; EXPERIMENTAL MOUSE; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; REGULATORY MECHANISM; ZINC FINGER MOTIF; ANIMAL; CHEMISTRY; CROSS BREEDING; GENE INACTIVATION; GENETICS; LETHAL GENE; METABOLISM; PROTEIN MULTIMERIZATION;

ANIMALS; CARRIER PROTEINS; CELL DEATH; CROSSES, GENETIC; GENE KNOCKOUT TECHNIQUES; GENES, LETHAL; LYSINE; MICE; PROTEIN MULTIMERIZATION; RECEPTORS, TUMOR NECROSIS FACTOR; UBIQUITINS; ZINC FINGERS;

EID: 84968928141     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01049-15     Document Type: Article

References (43)

1. Iwai K. 2012. Diverse ubiquitin signaling in NF-κB activation. Trends Cell Biol 22:355-364. http://dx.doi.org/10.1016/j.tcb.2012.04.001
2. Finley D. 2009. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78:477-513. http://dx.doi.org/10.1146/annurev.biochem.78.081507.101607
3. Deshaies RJ, Joazeiro CA. 2009. RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399-434. http://dx.doi.org/10.1146/annurev.biochem.78.101807.093809
4. Vucic D, Dixit VM, Wertz IE. 2011. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol 12:439-452. http://dx.doi.org/10.1038/nrm3143
5. Komander D, Rape M. 2012. The ubiquitin code. Annu Rev Biochem 81:203-229. http://dx.doi.org/10.1146/annurev-biochem-060310-170328
6. Dikic I, Wakatsuki S, Walters KJ. 2009. Ubiquitin-binding domains-from structures to functions. Nat Rev Mol Cell Biol 10:659-671. http://dx.doi.org/10.1038/nrm2767
7. Husnjak K, Dikic I. 2012. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81:291-322. http://dx.doi.org/10.1146/annurev-biochem-051810-094654
8. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, Sano S, Tokunaga F, Tanaka K, Iwai K. 2006. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 25:4877-4887. http://dx.doi.org/10.1038/sj.emboj.7601360
9. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M, Akira S, Takao T, Tanaka K, Iwai K. 2009. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 11:123-132. http://dx.doi.org/10.1038/ncb1821
10. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, Koschny R, Komander D, Silke J, Walczak H. 2009. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36:831-844. http://dx.doi.org/10.1016/j.molcel.2009.10.013
11. Fujita H, Rahighi S, Akita M, Kato R, Sasaki Y, Wakatsuki S, Iwai K. 2014. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex. Mol Cell Biol 34:1322-1335. http://dx.doi.org/10.1128/MCB.01538-13
12. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, Randow F, Wakatsuki S, Dikic I. 2009. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136:1098-1109. http://dx.doi.org/10.1016/j.cell.2009.03.007
13. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S, Tanaka K, Nakano H, Iwai K. 2011. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471: 633-636. http://dx.doi.org/10.1038/nature09815
14. Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J, Tokunaga F, Androulidaki A, Nakagawa T, Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B, Dikic I. 2011. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471:637-641. http://dx.doi.org/10.1038/nature09814
15. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW, Nachbur U, Gangoda L, Warnken U, Purcell AW, Silke J, Walczak H. 2011. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471:591-596. http://dx.doi.org/10.1038/nature09816
16. Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, Martinez-Barbera JP, Silke J, Rodriguez TA, Walczak H. 2014. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep 9:153-165. http://dx.doi.org/10.1016/j.celrep.2014.08.066
17. Rickard JA, Anderton H, Etemadi N, Nachbur U, Darding M, Peltzer N, Lalaoui N, Lawlor KE, Vanyai H, Hall C, Bankovacki A, Gangoda L, Wong WW, Corbin J, Huang C, Mocarski ES, Murphy JM, Alexander WS, Voss AK, Vaux DL, Kaiser WJ, Walczak H, Silke J. 2 December 2014. TNFR1-dependent cell death drives inflammation in Sharpindeficient mice. eLife 3:e03464. http://dx.doi.org/10.7554/eLife.03464
18. Kumari S, Redouane Y, Lopez-Mosqueda J, Shiraishi R, Romanowska M, Lutzmayer S, Kuiper J, Martinez C, Dikic I, Pasparakis M, Ikeda F. 2 December 2014. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 3:e03422. http://dx.doi.org/10.7554/eLife.03422
19. Sato Y, Fujita H, Yoshikawa A, Yamashita M, Yamagata A, Kaiser SE, Iwai K, Fukai S. 2011. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc Natl Acad Sci U S A 108:20520-20525. http://dx.doi.org/10.1073/pnas.1109088108
20. Lim S, Sala C, Yoon J, Park S, Kuroda S, Sheng M, Kim E. 2001. Sharpin, a novel postsynaptic density protein that directly interacts with the Shank family of proteins. Mol Cell Neurosci 17:385-397. http://dx.doi.org/10.1006/mcne.2000.0940
21. Alam SL, Sun J, Payne M, Welch BD, Blake BK, Davis DR, Meyer HH, Emr SD, Sundquist WI. 2004. Ubiquitin interactions of NZF zinc fingers. EMBO J 23:1411-1421. http://dx.doi.org/10.1038/sj.emboj.7600114
22. HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C. 1993. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol 143:972-982
23. Gijbels MJ ZC, Kraal G, Elliott GR, HogenEsch H, Schijff G, Savelkoul HF, Bruijnzeel PL. 1996. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol 148:941-950
24. Iwai K. 2011. Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis. Cell Cycle 10:3095-3104. http://dx.doi.org/10.4161/cc.10.18.17437
25. HogenEsch H, Janke S, Boggess D, Sundberg JP. 1999. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol 162:3890-3896
26. HogenEsch H, Torregrosa SE, Boggess D, Sundberg BA, Carroll J, Sundberg JP. 2001. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. Eur J Immunol 31:734-742. http://dx.doi.org/10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9
27. Seymour RE, Hasham MG, Cox GA, Shultz LD, Hogenesch H, Roopenian DC, Sundberg JP. 2007. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun 8:416-421. http://dx.doi.org/10.1038/sj.gene.6364403
28. Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C, Cook M, Finger J, Hughes-Earle A, Harris PA, Kaiser WJ, Mocarski ES, Bertin J, Gough PJ. 2014. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192:5476-5480. http://dx.doi.org/10.4049/jimmunol.1400499
29. Sasaki Y, Sano S, Nakahara M, Murata S, Kometani K, Aiba Y, Sakamoto S, Watanabe Y, Tanaka K, Kurosaki T, Iwai K. 2013. Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J 32:2463-2476. http://dx.doi.org/10.1038/emboj.2013.184
30. Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israel L, Trevejo-Nunez G, Bogunovic D, Cepika AM, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debre M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet JC, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Israel A, Casanova JL, Picard C. 2012. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 13:1178-1186. http://dx.doi.org/10.1038/ni.2457
31. Tamiya H, Terao M, Takiuchi T, Nakahara M, Sasaki Y, Katayama I, Yoshikawa H, Iwai K. 2014. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex. J Immunol 192:3793-3804. http://dx.doi.org/10.4049/jimmunol.1302308
32. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356. http://dx.doi.org/10.1074/jbc.274.43.30353
33. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700-714. http://dx.doi.org/10.1038/nrm2970
34. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. 2007. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 14:400-410. http://dx.doi.org/10.1038/sj.cdd.4402085
35. Kaczmarek A, Vandenabeele P, Krysko DV. 2013. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209-223. http://dx.doi.org/10.1016/j.immuni.2013.02.003
36. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS, Vucic D. 2010. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J 29:4198-4209. http://dx.doi.org/10.1038/emboj.2010.300
37. Sato Y, Yoshikawa A, Yamashita M, Yamagata A, Fukai S. 2009. Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3. EMBO J 28:3903-3909. http://dx.doi.org/10.1038/emboj.2009.345
38. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, Lidov HG, Hopkins G, Du L, Belkadi A, Chrabieh M, Itan Y, Picard C, Fournet JC, Eibel H, Tsitsikov E, Pai SY, Abel L, Al-Herz W, Casanova JL, Israel A, Notarangelo LD. 2015. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med 212:939-951. http://dx.doi.org/10.1084/jem.20141130
39. Wang K, Kim C, Bradfield J, Guo Y, Toskala E, Otieno FG, Hou C, Thomas K, Cardinale C, Lyon GJ, Golhar R, Hakonarson H. 2013. Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement. Genome Med 5:67. http://dx.doi.org/10.1186/gm471
40. Stieglitz B, Morris-Davies AC, Koliopoulos MG, Christodoulou E, Rittinger K. 2012. LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep 13:840-846. http://dx.doi.org/10.1038/embor.2012.105
41. Nilsson J, Schoser B, Laforet P, Kalev O, Lindberg C, Romero NB, Davila Lopez M, Akman HO, Wahbi K, Iglseder S, Eggers C, Engel AG, Dimauro S, Oldfors A. 2013. Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1. Ann Neurol 74:914-919. http://dx.doi.org/10.1002/ana.23963
42. MacDuff DA, Reese TA, Kimmey JM, Weiss LA, Song C, Zhang X, Kambal A, Duan E, Carrero JA, Boisson B, Laplantine E, Israel A, Picard C, Colonna M, Edelson BT, Sibley LD, Stallings CL, Casanova JL, Iwai K, Virgin HW. 20 January 2015. Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection. eLife 4:e04494. http://dx.doi.org/10.7554/eLife.04494
43. Dubois SM, Alexia C, Wu Y, Leclair HM, Leveau C, Schol E, Fest T, Tarte K, Chen ZJ, Gavard J, Bidere N. 2014. A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. Blood 123:2199-2203. http://dx.doi.org/10.1182/blood-2013-05-504019